These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17514651)

  • 1. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
    Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
    Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.
    Tchirkov A; Sapin V; Marceau G; Chautard E; Narla G; Veronese L; Friedman S; Khalil T; Vago P; Kemeny JL; Verrelle P
    Clin Chem Lab Med; 2010 Aug; 48(8):1167-70. PubMed ID: 20545576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
    Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
    Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.
    Fleischer M; Kessler R; Klammer A; Warnke JP; Eschrich K
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1010-20. PubMed ID: 21987444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
    Jeng YM; Hsu HC
    Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
    Kimmelman AC; Qiao RF; Narla G; Banno A; Lau N; Bos PD; Nuñez Rodriguez N; Liang BC; Guha A; Martignetti JA; Friedman SL; Chan AM
    Oncogene; 2004 Jun; 23(29):5077-83. PubMed ID: 15064720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
    Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
    Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
    Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
    Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
    Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
    Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.